Hospital 31

We Operate Exclusive High-Performance 

International Clinical Trial Investigative Sites







DELTA HEALTH collaborates with partner companies and healthcare organizations for managing clinical trial investigative sites based on the maxim.....EXPERIENCE.....INTEGRITY....QUALITY.


We have long-term exclusivity agreements with globally located prominent teaching hospitals and clinics to operate state-of-the-art clinical investigative sites having extensive experience in conducting drug development clinical trials according to GCP-ICH standards.


A number of these high-performance international investigative sites, covering a multi-ethnic catchment area population of 10 million plus, have preferred access to a fast growing, highly compliant local clinical trial subject populace. 


Independently audited and qualified from the United States and other countries, some of these clinical facilities are recipients of the prestigious "Best Clinical Trial Site" recognition. These international investigative sites, primarily focused on conducting Phase 1, Phase 2 and Phase 3 drug development clinical trials and having excellent patient retention rates, are directly managed by the DELTA HEALTH team members who have in-depth knowledge and hands-on experience with the operation and management of North American clinical trial investigative sites.

©1997 - 2020 DELTA HEALTH (And Its Global Affiliates Collectively). ALL RIGHTS RESERVED